Indication
Postherpetic neuralgia
Postherpetic neuralgia is a chronic neuropathic pain condition that represents the most common complication of herpes zoster (shingles), which arises from the reactivation of latent varicella-zoster virus within the sensory nervous system. Read more about Postherpetic neuralgia
250 drugs 152 manufacturers
Drugs that treat it
Common Postherpetic neuralgia therapies.
PREGABALIN
PREGABALIN
PREGABALIN
QUTENZA (capsaicin/skin cleanser)
PREGABALIN
PREGABALIN
LIDOCAINE PAIN RELIEF (lidocaine)
LIDOPURE PATCH (lidocaine/kinesiology tape)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPostherpetic neuralgia is a chronic neuropathic pain condition that represents the most common complication of herpes zoster (shingles), which arises from the reactivation of latent varicella-zoster virus within the sensory nervous system.
It disproportionately affects older adults and immunocompromised individuals.
Clinically, it is defined by persistent burning, lancinating, or aching pain—frequently accompanied by allodynia, hyperalgesia, and paresthesias—within the affected dermatome that continues for at least 90 days after the acute cutaneous rash has healed.
The underlying pathophysiology involves inflammatory damage and neurodegeneration of dorsal root ganglia and peripheral nerve fibers, resulting in peripheral sensitization and maladaptive central pain processing.
- nih.gov
Postherpetic neuralgia is a chronic neuropathic pain condition that represents the most common complication of herpes zoster (shingles), which arises from the reactivation of latent varicella-zoster virus within the sensory nervous system
- cdc.gov
Postherpetic neuralgia is a chronic neuropathic pain condition that represents the most common complication of herpes zoster (shingles), which arises from the reactivation of latent varicella-zoster virus within the sensory nervous system
- nih.gov
It disproportionately affects older adults and immunocompromised individuals
- nih.gov
It disproportionately affects older adults and immunocompromised individuals Clinically, it is defined by persistent burning, lancinating, or aching pain—frequently accompanied by allodynia, hyperalgesia, and paresthesias—within the affected dermatome that continues for at least 90 days after the acute cutaneous rash has healed
- nih.gov
Clinically, it is defined by persistent burning, lancinating, or aching pain—frequently accompanied by allodynia, hyperalgesia, and paresthesias—within the affected dermatome that continues for at least 90 days after the acute cutaneous rash has healed The underlying pathophysiology involves inflammatory damage and neurodegeneration of dorsal root ganglia and peripheral nerve fibers, resulting in peripheral sensitization and maladaptive central pain processing
- wikipedia.org
Clinically, it is defined by persistent burning, lancinating, or aching pain—frequently accompanied by allodynia, hyperalgesia, and paresthesias—within the affected dermatome that continues for at least 90 days after the acute cutaneous rash has healed The underlying pathophysiology involves inflammatory damage and neurodegeneration of dorsal root ganglia and peripheral nerve fibers, resulting in peripheral sensitization and maladaptive central pain processing
Personalize your experience
Follow Postherpetic neuralgia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.